12 Jun 2020 --- Royal DSM is prioritizing mergers and acquisitions following the potential economic fallout stemming from COVID-19. The company has canceled the remainder of its €1 billion (US$1.1 billion) share buy-back following the acquisition of Austria-based Erber Group, which has an enterprise value of €980 million (US$1.1 billion). Erber specializes in gut health performance management, mycotoxin risk management, and food and feed safety diagnostic solutions. This move significantly expands DSM’s health specialty and animal nutrition offerings.
